Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

GeneMedicine to begin phase I testing of IGF-I Gene Medicine

Jan. 9, 1997

Gene discovery collaboration announced

Jan. 9, 1997

ALRT announces new additions to the product pipeline

Jan. 9, 1997

Alendronate reduces occurrence of vertebral fractures in Fracture Intervention Trial

Jan. 9, 1997

Celtrix completes phase I studies of SomatoKine

Jan. 8, 1997

Leptin triggers reproductive function

Jan. 8, 1997

Bimoclomol progresses in trials

Jan. 8, 1997

Lilly synthesizes antiobesity proteins

Jan. 8, 1997

Kissei, Servier expand licensing agreement for antidiabetic drug

Jan. 7, 1997

Amgen, Progenitor sign agreement covering leptin receptor technology

Jan. 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...